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be carried out by a competent person. Many of these procedures are not daily
tasks, such as tusk removal in boars or ringing of bulls. On the horizon one sees
many objectionable maimings such as amputation of the penis in vasectomized
bulls to prevent intromission, amputation of the tongue in calves, and the possible insertion of electronic transponders in cattle. This is an area where we must
not abdicate our responsibilities. The role of the practitioner must continue in the
future to safeguard the well-being of our livestock by giving advice on care and
the prevention of neglect, as well as therapy to the sick and injured.
Welfare is team work. The practitioners will do the forward work, the half
back District Veterinary Offices will be at hand in any difficult situation, supported by the talents of Agricultural Development and Advisory Service (ADAS)
in the center and the universities on the wings. Very few problems should ever
reach the Minister of Agriculture at full back, but if one ever does let us hope he
will not put it out of play into touch, but give us an 'up and under' so that we can
all bring our expertise together to solve the problem.

It is now just over ten years since Medewar made the prediction that the
number of laboratory animals used every year would peak. Figures produced by
the U.K. authorities indicate that he was more or less correct. Although the number of recorded animal experiments in the U.K. has stabilized around 5.4 million
per annum and may even be falling, it is by no means clear whether this is due to
reduced funding and the increasing expense of laboratory animals or to the
development and adoption of alternatives (see Box). The most likely explanation
is that this peaking is the result of a combination of these and related factors.
Whatever the reason, we are entering the 80's amid a flurry of interest in and activity around the idea of "alternatives to laboratory animals."

Laboratory Animals and
Alternatives in the 80's

• reduce the amount of stress suffered by the animal by
REFINING the techniques used.

Andrew N. Rowan
Introduction
In 1969, Sir Peter Medewar, immunologist, Nobel prize-winner and philosopher of science, made the following statement at the Research Defence Society's
Annual Meeting:

The use of animals in laboratories to enlarge our understanding of nature is part of a far wider exploratory process, and
one cannot assay its value in isolation- as if it were an activity which, if prohibited, would deprive us only of the
material benefits that grow directly out of its own use. Any
such prohibition of learning or confinement of the understanding would have widespread and damaging consequences; but this does not imply that we are forevermore,
and in increasing numbers, to enlist animals in the scientific
service of man. I think that the use of experimental animals
on the present scale is a temporary episode in biological and
medical history, and that its peak will be reached in ten years
time, or perhaps even sooner. In the meantime, we must
grapple with the paradox that nothing but research on
animals will provide us with the knowledge that will make it
possible for us, one day, to dispense with the use of them
altogether (Medewar, 1972).
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In this discussion, an alternative is defined as any technique which
could:
• REPLACE the use of animals altogether;
• REDUCE the numbers of animals required;

At the same time, and this is most important, any alternative system must
provide data which leads to the same ultimate conclusion with the same
or greater degree of confidence as that obtained from the method being
replaced.
A clear example of this concept is provided by the experience of an
anti-viral screening program in a major pharmaceutical company
(Bucknall, R.A., 1980, The use of cultured cells and tissues in the
development of anti-viral drugs. In The Use of Alternatives in Drug
Research [eds A.N. Rowan and C.J. Stratmann] MacMillan: London, pp.
15-27). Over a period of fifteen years (up to 1977), the introduction of cell
and organ culture screening techniques reduced the number of mice required per annum from approximately 13,000 to about 2,000. At the same
time, the company was able to increase the number of compounds
screened for potential anti-viral properties from about 2,000 to about
24,000 per annum. There are a couple of instructive points in this example. First, the laboratory reduced rather than eliminated the use of mice.
The cell and organ culture systems could not mimic mammalian
·metabolism completely and, therefore, the final screening tests still had
to be conducted in the whole animal. Second, a great deal of time and
money was saved by doing the initial screening of compounds with
unknown potential in the faster and cheaper cell system. However,
although the time and cost benefits of alternative systems are indisputable, scientists do not always agree that the conclusions derived from
them are as valid as those derived from the animal system.

Europe
In Europe, the interest in alternatives has grown steadily ever since the
Council of Europe adopted Recommendation 621 in 1971. (The Council of Europe
is a loosely-knit treaty organization of 21 European countries). This Recommendation was a radical document which, inter alia, called for the drafting of international legislation to set out the conditions under which experiments on live ani/NT 1 STUD ANIM PROB 1(3] 1980
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mals may be authorized and, specifically, for the establishment of a major international clearinghouse on alternatives. At present, the Council of Europe's expert
committee is completing a draft treaty on laboratory animals which is considerably watered down from the original Recommendation. Interest in alternatives has, in the meantime, grown significantly, and several of the European nations have publicly supported the concept.
In Britain, Mr. Callaghan, as Prime Minister, issued the following answer to a
question in Parliament about his Government's intentions vis-a-vis alternatives:

I hope I have indicated that it would certainly be our policy
and desire to move to alternatives to animal experiments as
quickly as possible, and our efforts must be directed in that
way [Hansard, 8 Dec 1977, Cots 1642-1644).
The Home Office (which administers The Cruelty to Animals Act, 1876) backed
up the Prime Minister's statement by sending out a letter exhorting all scientists
in Britain who are licensed to perform experiments on living animals to "take
every reasonable step to confirm, before using living animals, that their investigations" could not be effectively carried out by other means. The letter continued
by urging the licensees "to give thought to the possibilities of developing new
alternatives to the use of living animals and to publishing information about successful new methods." According to reports, this letter caused some resentment
among biomedical researchers, but it certainly demonstrated the Government's
public commitment to the idea.
In continental Europe, the Federal Republic of Germany included a section
on alternatives in its Animal Protection Law of 1972 which stated that potentially
injurious experimentation would only be authorized if the research could not be
done on nonanimal systems or on phyletically lower animals. In Denmark, the
1953 law on experimental animals was amended on May 13,1977 to forbid painful experiments in schools and to allow experiments on live animals only after
due permission is obtained from a national committee composed of four scientists, a lawyer and three representatives from the Danish Society for the Prevention of Cruelty to Animals. Also in 1977, the Dutch Parliament enacted legislation
which placed heavy emphasis on the requirement that those dealing with
laboratory animals have adequate professional skill and that "no animal experiment shall be conducted for a purpose that, according to the consensus of opinion among experts, could equally well be achieved in some other way." At last
year's (1979) meeting of the International Committee for Laboratory Animal
Science in Utrecht, the Dutch Minister of Health and Enviromental Protection,
Dr. Ginjaar, drew specific attention to this point and stated that "The
Netherlands endorses a suggestion made in the Council of Europe's Committee of
Experts on the Protection of Animals that the matter of alternatives be promoted
at the European level."
Outside the European Economic Community (EEC), Sweden has recently
established a governmental advisory Central Committee on Experimental
Animals, one of whose responsibilities is the development and promotion of
alternatives. Approximately $90,000 has been distributed to research projects
dealing with alternatives, and a section on alternatives is to be included in a
164
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course for veterinary students this year. Sweden also passed a law at the end of
1978 making reviews of animal experiments by ethical committees in government
institutions mandatory. Elsewhere, the Swiss Federal Assembly passed a new
animal welfare law in December 1978 which is expected to be put into force in
mid-1980.
Animal welfare and anti-vivisection societies in Europe are not only encouraged by recent government activity, but are themselves encouraging scientists to consider the concept of alternatives by making grant money available for
research. One such organization in Britain, the Lord Dowding Fund for Humane
Research, held a meeting in the last quarter of 1979 to discuss the results of
research which it has been supporting (New Scientist 84:271-272, 1979). As is not
uncommon in scientific progress, the results were rather mixed.
Dr. Derek Calam of the National Institute for Biological Standards and Control (London) has been working on a high-performance liquid chromatography
(HPLC) method for assaying "biological medicines" such as insulin and oxytocin
which are currently standardized in potency assays using animals. However,
Calam is having difficulty obtaining reproducible results although the HPLC
method is potentially sensitive enough (±3% accuracy) to meet the regulatory
requirements of ±10% accuracy for oxytocin potency assays.
Dr. Peter Knox of St. George's Hospital Medical School (London) is studying
the nutrient requirements of cells in culture. He argues that cell culture
technology is still in its infancy and needs to be improved so that it may become
a more useful alternative. The blood serum supplement, which normally is added
to cell culture nutrient media, contains a large number of constitutents, most of
which are unidentified. It is not known which constituents, and in what combination, are essential to normal cell growth. Knox has been working on this very complex problem and has isolated two proteins which appear to play a role in cell
adhesion to the petri dish, a vital step in the growth process, and is following up
on this finding.
Research on these or similar techniques is, of course, being supported by
establishment organizations. However, the animal welfare trusts serve to focus
attention on the potential of these techniques as alternatives.

The United States-Arguing the "Alternatives" Concept
The idea of alternatives is coming of age in Europe, but progress in the
United States is a little slower. There have been one or two meetings at which the
subject has been addressed- notably the ConMed Symposium in Cincinnati last
year organized by the Department of Laboratory Animal Medicine at the University of Cincinnati. The National Institutes of Health is also considering a proposal
to hold a major conference on the topic.
Furthermore, following the success of the Lord Dowding Fund in Britain, an
"alternatives" funding organization has been established in New York (American
Fund for Alternatives to Animal Research [AFAAR], 175 West 12th Street, New
York, NY 10011). On January 19,1980, AFAAR organized a small meeting at which
two scientists who have received funds for alternatives research described their
work. Professor Oscar Frank of the New jersey Medical School discussed his
work on microbial vitamin and amino acid assays, their potential for studying
/NT I STUD ANIM PROB 1(3} 1980
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vitamin deficiency disorders, and the role played by drug anti-metabolites. One
protozoan, Tetrahymena pyriformis has the same amino acid requirements as
man and the rat (the usual laboratory animal for testing protein quality). Professor Frank and his group have developed a technique which allows them to use
the protozoan rather than the rat as the test animal for protein quality, and
AFAAR is funding research into other applications of the assay. Dr John Petrieciani of the Food and Drug Administration's Bureau of Biologics and scientific
advisor to AFAAR, described research in his laboratory to develop an organ
culture assay (using chick embryonic skin) to measure the tumorigenic potential
of cells. Usually, tumorigenic potential is assessed in an immunosuppressed
animal or in the nude mouse, but Petricciani argues that the chick embryonic skin
test is more sensitive, quicker and less expensive than the animal test. He also
stated that there are other areas where animal models are still required; e.g., to
assess the metastasis (spreading) potential of a tumor.
·Despite these developments, many American research scientists still express
some uneasiness about the concept of alternatives. A frequent argument is that
one cannot predict the outcome of research and, therefore, allocating funds for
the development of alternatives would be a mistake. This argument fails to take
into account a number of features about research in general and the alternatives
concept in particular. First, funds are allocated for particular areas of research in
the hope that this will stimulate the generation of good ideas and research projects. Second, the development and application of new techniques is an important
part of the research process and it frequently is possible to predict the benefits o_f
better techniques. Conversely, the application of greater resources to a multifaceted research problem, in which not even the correct questions are known,
can confound predictions. This is exemplified by the failure of the "war on
cancer."
The advance of biomedical knowledge depends on a number of factors including an adequate reserve of imagination and intuition and sufficient funds,
equipment and manpower for the critical evaluation and testing of new ideas.
Imagination and critical review are the basis of the hypothetico-deductive model
of scientific advance, but two other factors must also be included: luck and technique development. The importance of technique development is attested to_by
the number of awards given to scientists who develop new methods for attackmg
old problems. For example, Dr. Rosalyn Yalow received a Nobel price in 1977 for
her part in the development of the radio-immunoassay technique. This technique
has been cited as an alternative because it allows a researcher to assay very small
amounts of complex biological molecules which previously could only have
been done (if, indeed, it was possible at all) by using living animals.
The alternative technique which has raised the highest hopes among animal
welfare organizations is tissue culture. Bernard Dixon argues in his book, What Is
Science For (Penguin, 1972, pg 31), that when medical researchers look back
through the decades, they will select as one of the most important single developments in the 1960's the technical innovations leading to the growth and study
of human cells in the laboratory. As stated earlier, the technique is still in its infancy. If more research resources were devoted to improving and developing cell
culture techniques, the investigation of many research problems would be simplified. For example, an understanding of the complete growth requirements of
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human cells would probably have a major impact on our understanding of differentiation and malignant growth.
The National Institutes of Health already recognizes the importance of supporting technical developments through its Biotechnology Resources program in
the Division of Research Resources (ORR). The ORR provided $11.8 million in
1976 to assist in the support and acquisition of complex technological capabilities for qualified research scientists, but a 1976 report on the ORR mission (known
as the Bolt, Beranek and Newman Report after the name of the consultancy organization which managed the review), had the following to say about the biotechnology program:

The Panel finds this program to be substantially underfunded even for its current portfolio. Furthermore, the Biotechnology Resources Board should address the challenges
inherent in biotechnology needs by adding activities in new
directions. Specifically, support should be given to preresource development of biomedically-relevant technologies before they are mature enough to serve a user community.
Therefore, the Bolt, Beranek and Newman report implicitly supports the idea of
developing new techniques (which would include alternatives) and also argues
that the ORR is not adequately fulfilling its function of conceiving and creating
such new resources. The application of funds specifically to the deveiQpment of
cell culture technology, to the training of scientists in tissue culture techniques
and to the dissemination of appropriate information on all research models (not
just animal models as is currently the case) would definitely fall within the purview of the ORR.
The ORR currently provides approximately $14 million per annum to maintain seven primate centers around the country. It is arguable that, if these funds
had been devoted specifically to the development and application of cell culture
technology, the subsequent advances in biomedical knowledge would have been
more significant than those emanating from the primate centers. Animal welfare
groups believe that there is too little attention paid to in vitro versus animal
research models and are therefore attempting to direct research funds to the
development and application of alternative techniques via congressional action.
As a result, three Bills have been introduced into the U.S. House of Representatives in 1979.

The United States-Legislative Activity
The first Bill, H.R. 282, was introduced by Congressman Drinan (0-MA). This
Bill is relatively straightforward and uncontroversial. It calls upon Congress to
allocate $12 million to the development of alternative techniques. Most animal
welfare advocates consider that the bill is too modest. The second Bill, H.R. 4479,
was introduced by Congressman Weiss (0-NY), and it mandates the establishment
of a Commission to study alternative methods to the use of live animals in
research and testing. The Bill requires that individuals appointed to the Commis/NT f STUD ANIM PROB 1(3] 1980
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groups believe that there is too little attention paid to in vitro versus animal
research models and are therefore attempting to direct research funds to the
development and application of alternative techniques via congressional action.
As a result, three Bills have been introduced into the U.S. House of Representatives in 1979.

The United States-Legislative Activity
The first Bill, H.R. 282, was introduced by Congressman Drinan (0-MA). This
Bill is relatively straightforward and uncontroversial. It calls upon Congress to
allocate $12 million to the development of alternative techniques. Most animal
welfare advocates consider that the bill is too modest. The second Bill, H.R. 4479,
was introduced by Congressman Weiss (0-NY), and it mandates the establishment
of a Commission to study alternative methods to the use of live animals in
research and testing. The Bill requires that individuals appointed to the Commis/NT f STUD ANIM PROB 1(3] 1980
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sian should include representatives from animal welfare groups, biomedical
research organizations and veterinarians. The Commission would have a maximum of five years for the investigation and an annual budget of not more than

$750,000.
The third and most recent Bill, H.R. 4805, was introduced on July 16,1979
and is sponsored by Congressmen Richmond (D-NY), Roe (D-NJ), Hollenbeck
(R-NJ) and Wolff (D-NY). It is based on a draft bill drawn up by United Action for
Animals. This Bill mandates the establishment of a National Center for Alternative Research to increase the use of existing alternatives, to encourage the development of more alternatives, to provide for the training of scientists in the use
of such alternatives, to eliminate duplication and repetitive research on live
animals, and to disseminate information on alternatives. The National Center,
directed by representatives of all the federal agencies who fund animal research,
would be required to publish an annual report of how the goals of the Bill are being met. Finally, the Bill mandates the re-allocation of 30-50% of all appropriations for live animal research and testing to the development of alternatives.
The presence of three bills in the House of Representatives promoting the
idea of alternatives has generated widespread interest in the subject in the
United States. For example, the General Accounting Office has been requested to
investigate whether or not research would benefit from the allocation of funds
specifically to the development of alternatives and the National Institutes of
Health has been conducting its own in-house survey on the extent to which it currently funds research utilizing techniques which fall within the "alternatives"
classification. However, scientific organizations are unenthusiastic about all of
the Bills. Although the Drinan Bill (H.R. 282) is not controversial and would provide additional funding to scientists, an official letter from the Department of
Health, Education and Welfare comments that, although the Department supports the purpose of this bill, it "questions the need for specific authorization."
The National Institutes of Health and other scientific organizations are, not surprisingly, much more strongly opposed to the more radical and sweeping H.R.

4805.
A major attraction of H.R. 4805 to members of the present Congress is that
the Bill does not require additional funding. However, biomedical research funding agencies are unhappy about the restraints that the bill would place on their
activities, and many regard it as being anti-science. United Action for Animals
has publicized the Bill widely, and it has vocal support among members of
animal welfare organizations, and support from some establishment sources. For
example, the Christian Science Monitor carried an editorial about the Bill on
October 25, 1979 in which they stated that "such legislation would not inhibit any
essential research but might help foster a moral climate in which greater emphasis is placed on humane consideration of the life of all living creatures. It
deserves public support." There has been a mixed response from the animal welfare groups themselves. The Society for Animal Rights opposes the Bill because it
"clearly implies that the vivisection of animals is acceptable and necessary until
such time as alternatives are discovered and put into use" (SAR Report,
December 1979). The Humane Society of the United States is committed to support for the principle of alternatives, but considers that H.R. 4805 will have to be
modified if it is to have any chance of enactment against the opposition of the
168

/NT I STUD ANIM PROB 1(3} 1980

I

A.N.Rowan

Comment!

very powerful research lobby.
H.R. 4805 and the other Bills are serving a useful purpose in raising the consciousness of the political public and in forcing scientific organizations to pay
greater attention to the question of alternatives. It is not unlikely that some sort
of "alternatives" bill could be passed in the next decade as the subject comes
under closer and closer scrutiny. In order for such a bill to satisfy the animal welfare community, it would have to contain elements which provided substantial
funding for the development of alternatives, which provided for the training of
scientists and the dissemination of relevant information, and which tackled the
problems of unscientific duplication and repetitive research. On the other hand,
if such a bill is to be acceptable to a reasonable proportion of biomedical researchers, then it will have to be perceived as a constructive development. In
fact, the research constituency is still apprehensive about the whole concept of
alternatives and much groundwork is still required, employing technical and
scholarly arguments, to persuade biomedical scientists that the concept is not
only valid but that it can also be valuable.
At the very least, generation of a positive attitude toward alternatives
should lead to better planning of research and to the use of the most appropriate
research models. At the very most, the development of in vitro research models
can lead to significant new research opportunities. According to Professor Sergey
Federoff, past president of the Tissue Culture Association, "the application of
tissue cultures to biomedical research is limited only by the imagination of the
scientists employing them."

Dr. Rowan is the author of Alternatives to Laboratory Animals,
which is a review of the scientific and technical aspects of alternatives
and an examination of the potential and the limitations of the alternatives concept. The monograph contains detailed information on
animal use in various types of biomedical research, a description of
alternative techniques and their applicability to specific research
areas, as well as extensive references and a selected bibliography
covering the ethics, history and legal aspects of animal experimentation. Alternatives to Laboratory Animals is available at a cost of $2.00
from the Institute for the Study of Animal Problems, 2100 L St. 1'-IW,
Washington, DC 20037, USA.
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deserves public support." There has been a mixed response from the animal welfare groups themselves. The Society for Animal Rights opposes the Bill because it
"clearly implies that the vivisection of animals is acceptable and necessary until
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H.R. 4805 and the other Bills are serving a useful purpose in raising the consciousness of the political public and in forcing scientific organizations to pay
greater attention to the question of alternatives. It is not unlikely that some sort
of "alternatives" bill could be passed in the next decade as the subject comes
under closer and closer scrutiny. In order for such a bill to satisfy the animal welfare community, it would have to contain elements which provided substantial
funding for the development of alternatives, which provided for the training of
scientists and the dissemination of relevant information, and which tackled the
problems of unscientific duplication and repetitive research. On the other hand,
if such a bill is to be acceptable to a reasonable proportion of biomedical researchers, then it will have to be perceived as a constructive development. In
fact, the research constituency is still apprehensive about the whole concept of
alternatives and much groundwork is still required, employing technical and
scholarly arguments, to persuade biomedical scientists that the concept is not
only valid but that it can also be valuable.
At the very least, generation of a positive attitude toward alternatives
should lead to better planning of research and to the use of the most appropriate
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can lead to significant new research opportunities. According to Professor Sergey
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scientists employing them."

Dr. Rowan is the author of Alternatives to Laboratory Animals,
which is a review of the scientific and technical aspects of alternatives
and an examination of the potential and the limitations of the alternatives concept. The monograph contains detailed information on
animal use in various types of biomedical research, a description of
alternative techniques and their applicability to specific research
areas, as well as extensive references and a selected bibliography
covering the ethics, history and legal aspects of animal experimentation. Alternatives to Laboratory Animals is available at a cost of $2.00
from the Institute for the Study of Animal Problems, 2100 L St. 1'-IW,
Washington, DC 20037, USA.

/NT I STUD ANIM PROB 1(3} 1980

169

